Cannabichromene (CBC) is one of more than 120 compounds called cannabinoids found in the plant species Cannabis sativa. The most psychoactive of these is tetrahydrocannabinol (THC), but CBC has also been shown to have pain-relieving properties and thus may be helpful for patients who do not benefit from THC.
The most studied cannabinoids are THC, which has well-known psychoactive properties, and cannabidiol (CBD), which is being used therapeutically in patients with neuropathic pain. However, research on CBC has also yielded results with therapeutic potential for relief of pain symptoms without the psychoactive effect of THC.
Other research suggests that CBC is an effective anti-inflammatory and antioxidant, explaining its potential in treating neurodegenerative diseases such as Alzheimer’s and multiple sclerosis (MS). CBC is available in capsule form from suppliers of cannabinoid products at a cost that makes it feasible for researchers to conduct studies on patients who suffer from specific conditions and symptoms. To date, research suggests it may be helpful in the following ways:
Analgesic Agent
CBC can also help relieve neuropathic pain symptoms due to damage or dysfunction in the nervous system. It has also been shown to block nerve conduction, yielding further benefits for patients with neuropathic pain conditions.
Anti-Inflammatory And Antioxidant Properties
Research suggests that CBC, which can also be taken in the form of CBC capsules, can help patients with inflammatory conditions, such as Crohn’s disease and rheumatoid arthritis. In addition, it has been shown to reduce swelling in animals’ joints.
Antidepressant Properties
CBC can be used in patients who do not respond well to traditional antidepressants to help combat symptoms of mood disorders. CBC has also been shown to promote neurogenesis in the hippocampus, leading to improved memory function; it may be helpful in patients who have Alzheimer’s disease.
Anti-Cancer Properties
CBC is known to affect apoptosis (programmed cell death) in certain cancer cells by activating pathways that cause these cells to self-destruct, potentially suggesting a new avenue for treating tumors. CBC is the most studied of the cannabinoids. As scientific research has yielded promising results in treating conditions that affect millions of people worldwide, CBC capsules may be useful for patients who do not benefit from traditional analgesic agents and antidepressants or for patients with inflammatory conditions.
For more valuable information visit the website
